INCY:NASDAQ
Incyte Corp
$121.74
arrow_downward
-0.37%(-0.45) 1D
$121.74
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$121.58
High
$122.19
Low
$119.97
Mkt. cap
24.68B
Avg. vol.
1.34M
Volume
41.00
P/E ratio
15.51
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$121.58
High
$122.19
Low
$119.97
Mkt. cap
24.68B
Avg. vol.
1.34M
Volume
41.00
P/E ratio
15.51
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
StockStory
·
2 hours ago
1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
Simply Wall Street
·
8 hours ago
Incyte (INCY) Stock Could Be 30% Overvalued As MINJUVI Funding Lands
Seeking Alpha
·
1 day ago
Incyte: Priced For Success, With No Margin Of Safety (NASDAQ:INCY)
ad-hoc-news.de
·
1 day ago
Incyte stock heads into the open after a 0.2 percent slip
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com